China Pharma Holdings (CPHI) Cash & Equivalents Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 69.13% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 2.86% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 19.56% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 13.19% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 56.51% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 25.91% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -1.67% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | -4.65% |
| 10 | China Pharma Holdings | 41.34 Mn | 41.03 Mn | 83,566.00 | -51.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.18% |
| Dec 31, 2025 | -44.95% |
| Sep 30, 2025 | -62.76% |
| Jun 30, 2025 | -15.46% |
| Mar 31, 2025 | -50.80% |
| Dec 31, 2024 | -55.97% |
| Sep 30, 2024 | -47.54% |
| Jun 30, 2024 | -18.03% |
| Mar 31, 2024 | -28.11% |
| Dec 31, 2023 | -29.86% |
| Sep 30, 2023 | -34.77% |
| Jun 30, 2023 | -59.00% |
| Mar 31, 2023 | -68.59% |
| Dec 31, 2022 | -58.22% |
| Sep 30, 2022 | 320.00% |
| Jun 30, 2022 | 22.22% |
| Mar 31, 2022 | 594.97% |
| Dec 31, 2021 | 407.39% |
| Sep 30, 2021 | 42.86% |
| Jun 30, 2021 | -0.75% |